Quality Control: Operator Error: Is It Really the Root Cause of Performance Problems? - - BioPharm International

ADVERTISEMENT

Quality Control: Operator Error: Is It Really the Root Cause of Performance Problems?


BioPharm International
Volume 19, Issue 12

REFERENCES

1. Suzaki K. The new shop floor management: empowering people for continuous improvement. New York: Free Press; 1993. p. 391.

2. Mager R., Pipe P. Analyzing performance problems. Belmont, CA: Lake Publishing; 1984.

3. Broad ML, Newstrom JW. Transfer of training: action-packed strategies to ensure high payoff from training investments. Scranton, PA: Addison-Wesley Perseus Press; 1992.

4. Mager R. Measuring instructional results. Belmont, CA: Lake Publishing; 1984.

5. Bringslimark V. If training is so easy, why isn't everyone in compliance? BioPharm Int. 2004;17(1):46–53.

6. Clark RC. Developing technical training: a structured approach for the development of classroom and computer based instructional materials. Phoenix, AZ: Buzzards Bay Press; 1994. p. 41.

7. Silberman A. Active training. New York: Lexington Books; 1990. p. 95.

SUGGESTED READING

Association for the Advancement of Medical Instrumentation; The quality system compendium: GMP requirements and industry practice. Arlington, VA; 1998.

Brookfield S. Understanding and facilitating adult learning. San Francisco: Jossey-Bass; 1986.

Carr, C. Smart training: the manager's guide to training for improved performance. New York: McGraw-Hill; 1992.

Jacobs RL, Jones MJ. Structured on-the-job training: unleashing employee expertise in the workplace. San Francisco: Berrett-Koehler; 1995.

Mager R. Preparing instructional objectives. Belmont, CA: Lake Publishing; 1984.

Rothwell WJ, Kazanas HC. Improving on-the-job training: how to establish and operate a comprehensive OJT program. San Francisco: Jossey-Bass; 1994.

Senge P, Kleiner A, Roberts C, Ross R, Smith B. The fifth discipline fieldbook. New York: Doubleday; 1994. p. 127.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
AbbVie's Acquisition of Shire Could Save $8 Billion in Taxes
July 21, 2014
AstraZeneca Reveals Design for New Global R&D Center and Corporate Headquarters
July 18, 2014
AbbVie to Acquire Shire for $54.7 Billion
July 18, 2014
Particulate Matter Prompts Baxter's Recall of IV Solutions
July 17, 2014
Author Guidelines
Source: BioPharm International,
Click here